상세 보기
Carvedilol versus Propranolol in Patients with Hepatocellular Carcinoma: A Nationwide Cohort Study
- Song, Byeong Geun;
- Lee, Myeongcheol;
- Cho, Juhee;
- Gwak, Geum-Youn;
- Kang, Danbee;
- ... Sinn, Dong Hyun
WEB OF SCIENCE
0SCOPUS
0초록
Introduction: Beta-blockers reduce portal hypertension; however, evidence comparing carvedilol and propranolol in patients with hepatocellular carcinoma (HCC) is lacking. We aimed to compare the clinical outcomes of carvedilol versus propranolol in patients with HCC. Methods: Using the Korean National Health Insurance Service database (2009-2023), we identified 11,124 patients with newly diagnosed HCC who were prescribed either carvedilol (n = 2,457) or propranolol (n = 8,667) within 180 days of diagnosis. The primary outcome was all-cause mortality, and the secondary outcome was hepatic decompensation. Multivariable Cox regression and 1:2 PS matching were used as primary analytical approaches, with sensitivity analyses restricted to 6-month survivors and a new-user design. Results: During a median follow-up of 1.5 years, carvedilol use was associated with a significantly lower risk of hepatic decompensation (adjusted hazard ratio [aHR] 0.67; 95% confidence interval [CI] 0.62-0.72) and all-cause mortality (aHR 0.84; 95% CI 0.79-0.90) compared to propranolol. In the 1:2 PS-matched cohort (n = 5,922), these associations remained consistent for both decompensation (HR 0.68; 95% CI 0.63-0.74) and mortality (HR 0.84; 95% CI 0.78-0.90). These benefits were consistent across various subgroups, and in sensitivity analysis excluding early death within 6 months from diagnosis and using a new-user design. Conclusion: In patients with HCC, carvedilol was associated with better survival and lower risk of hepatic decompensation than propranolol. Carvedilol may be the preferred beta-blocker over propranolol in the setting of HCC.
키워드
- 제목
- Carvedilol versus Propranolol in Patients with Hepatocellular Carcinoma: A Nationwide Cohort Study
- 저자
- Song, Byeong Geun; Lee, Myeongcheol; Cho, Juhee; Gwak, Geum-Youn; Kang, Danbee; Sinn, Dong Hyun
- 발행일
- 2026-06
- 유형
- Article; Early Access
- 저널명
- Liver Cancer
- 페이지
- 1 ~ 11
- 언어
- ENG
- 출판사
- KARGER
- 발행국가
- 스위스
- 분량
- 11 페이지
- ISSN
- E 1664-5553
P 2235-1795